Paper · 41501031
Emerging roles of tRNA modification-mediated codon-specific translational reprogramming in cancer biology.
Wang H and 3 others. Cell Death Dis, 2026. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Emerging roles of tRNA modification-mediated codon-specific translational reprogramming in cancer biology. Papers, record 41501031. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41501031
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Emerging roles of tRNA modification-mediated codon-specific translational reprogramming in cancer biology.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| RNA, Transfer | Major topic |
| Neoplasms | Major topic |
| Protein Biosynthesis | Major topic |
| Codon | Major topic |
| Humans | |
| Animals |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82273367 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82303383 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 2024J09033 | Natural Science Foundation of Fujian Province (Fujian Provincial Natural Science Foundation) | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References258
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20,382,657 | Biosynthesis of wyosine derivatives in tRNA: an ancient and highly diverse pathway in Archaea. | Mol Biol Evol | 2010 | https://conductscience.org/library/papers/20382657 | PubMed |
| 2 | 16,826,519 | Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. | Am J Hum Genet | 2006 | https://conductscience.org/library/papers/16826519 | PubMed |
| 3 | 35,965,412 | Targeting N7-methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation. | Mol Ther | 2023 | https://conductscience.org/library/papers/35965412 | PubMed |
| 4 | 37,531,210 | TRMT61B rs4563180 G>C variant reduces hepatoblastoma risk: a case-control study of seven medical centers. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/37531210 | PubMed |
| 5 | 35,681,060 | tRNA dysregulation and disease. | Nat Rev Genet | 2022 | https://conductscience.org/library/papers/35681060 | PubMed |
| 6 | 21,775,533 | Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21775533 | PubMed |
| 7 | 36,467,585 | N1-methyladenosine modification in cancer biology: Current status and future perspectives. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/36467585 | PubMed |
| 8 | 40,461,825 | TRMT6-mediated tRNA m1A modification acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression. | Nat Cancer | 2025 | https://conductscience.org/library/papers/40461825 | PubMed |
| 9 | 33,152,999 | How Elongator Acetylates tRNA Bases. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33152999 | PubMed |
| 10 | 33,777,092 | RNA-Binding Proteins Play an Important Role in the Prognosis of Patients With Testicular Germ Cell Tumor. | Front Genet | 2021 | https://conductscience.org/library/papers/33777092 | PubMed |
1 to 10 of 258
See all 258 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,890,856 | tRNA regulatory ecosystem states shape tissue and circulating small-RNA landscapes in gastric cancer. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42890856 | PubMed |
| 42,637,820 | DREAMS illuminates spatial DNA and RNA modification landscapes. | Nat Cell Biol | 2026 | https://conductscience.org/library/papers/42637820 | PubMed |
| 42,490,959 | Transfer RNA expression, modification, and derived small RNAs in cancer biology and clinical potential. | Front Immunol | 2026 | https://conductscience.org/library/papers/42490959 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41501031
GET https://conductscience.org/api/papers/v1/41501031/references?page=2